- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
806
0 new
Companies which are more than 50% undervalued based on analyst price target.
806 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
BIIB | US$157.90 | -1.3% | -31.9% | US$23.0b | US$251.70 | PE14.2x | E12.4% | n/a | ||
MRNA | US$41.11 | 11.6% | -47.6% | US$15.8b | US$77.55 | PS3.1x | E17.9% | n/a | ||
RPRX | US$26.43 | 2.8% | -2.3% | US$15.6b | US$41.53 | PE10.3x | E6.3% | 3.2% | ||
SMMT | US$19.00 | 3.8% | 850.0% | US$14.0b | US$34.27 | PB32x | S85.4% | n/a | ||
GMAB | DKK 1,483.50 | 2.3% | -31.3% | DKK 94.2b | DKK 2,395.00 | PE20x | E23.7% | n/a | ||
BMRN | US$64.26 | 1.3% | -27.1% | US$12.2b | US$98.39 | PE38x | E27.3% | n/a | ||
PCVX | US$88.54 | 2.0% | 79.5% | US$11.0b | US$151.75 | PB3.2x | E-4.5% | n/a | ||
SRPT | US$114.23 | 9.3% | 37.8% | US$10.9b | US$189.62 | PE89.5x | E42.6% | n/a | ||
4523 | JP¥4,650.00 | -7.5% | -40.2% | JP¥1.3t | JP¥7,127.94 | PE32x | E13.1% | 3.4% | ||
LEGN | US$40.94 | 7.2% | -32.3% | US$7.5b | US$82.55 | PS14.4x | E70.5% | n/a | ||
GRF | €10.60 | -4.7% | -19.0% | €6.6b | €17.07 | PE44.6x | E33.3% | n/a | ||
VKTX | US$52.59 | 6.1% | 328.3% | US$5.9b | US$112.57 | PB6.4x | E-1.8% | n/a | ||
6446 | NT$569.00 | -3.7% | 58.7% | NT$189.1b | NT$853.50 | PE102.4x | E92.0% | n/a | ||
CYTK | US$49.10 | -2.2% | 53.6% | US$5.8b | US$81.41 | PS1800.1x | E36.7% | n/a | ||
IONS | US$34.01 | -1.0% | -31.7% | US$5.4b | US$61.36 | PS6.7x | E32.9% | n/a | ||
300765 | CN¥27.26 | 5.7% | -11.6% | CN¥38.0b | CN¥40.96 | PE74x | E37.5% | 1.0% | ||
RNA | US$43.25 | 2.5% | 590.9% | US$5.2b | US$68.55 | PS510x | E32.4% | n/a | ||
BBIO | US$23.42 | -1.3% | -20.8% | US$4.4b | US$46.89 | PS20.3x | E30.8% | n/a | ||
RARE | US$47.24 | 5.6% | 20.7% | US$4.4b | US$92.43 | PS8.3x | E54.2% | n/a | ||
CRSP | US$47.88 | 1.3% | -31.6% | US$4.1b | US$81.54 | PS20.1x | E34.5% | n/a | ||
IMVT | US$26.87 | 0.9% | -19.6% | US$3.9b | US$48.93 | PB8.8x | E8.3% | n/a | ||
IBRX | US$5.10 | 13.6% | 23.8% | US$3.6b | US$14.25 | PS484.7x | E72.9% | n/a | ||
DNLI | US$24.69 | -1.4% | 34.1% | US$3.6b | US$41.69 | PB2.7x | E25.6% | n/a | ||
MRUS | US$45.49 | -2.3% | 88.4% | US$3.1b | US$85.64 | PS86.7x | E19.1% | n/a |